Fungal infections are becoming more prevalent especially with increase in immunodeficiency disorders, immunosuppression following transplantation, cancers and cancer treatment. They are ubiquitous and cause infections which may be trivial or more deep seated and severe infections associated with mortality. The ability of some fungal species to cause disease is due to various virulence factors which help with fungal survival and persistence in the host resulting in tissue damage and disease. This review discusses these virulence factors. These factors include an ability to adhere to hosts' tissues, production of enzymes that cause tissue damage and direct interference with host defences. Pathogenic fungi produce catalases and Mannitol which protect against reactive oxygen species (ROS). Some fungi notably, dimorphic fungi and C. albicans have the ability to switch from one form to another. Thermotolerance, at least to 37 0 C, is critical for survival in mammalian host and contributes to dissemination. Melanin is produced by a number of pathogenic fungi, and protects against harsh conditions such as UV radiation, increased temperature and ROS. The ability to obtain Iron (Fe) from the storage or transport forms in the host is also a virulence factor and calcineurin acts as a sensor for pathogenic fungi. 
INTRODUCTION
Fungal infections have become very prevalent with associated increase in mortality and morbidity. This is especially so for life-threatening invasive fungal infections as a result of increase in immunodeficiency disorders such acquired immune deficiency syndrome (AIDS), cancer and cancer treatment, and immunosuppressive therapy following transplantation. Fungi are ubiquitous, they cause infections when the spores are inhaled, e.g. Aspergillus fumigatus; by direct skin contact or implantation e.g. Trichophytonrubrum, or by commensals when there are changes in the host's normal flora or breech in mucosal barrier as seen with Candida albicans. However, for most immunocompetent individuals, immune mechanisms are able to control and contain these fungal infections. Fungi cause different disease types; the very common superficial infections, e.g. ringworm or onychomycosis caused by the dermatophytes-T.rubrum, invasive or deep-seated severe infections such as meningitis or pneumonia caused by C. immitisor C. neoformansand allergic diseases in atopic hosts, e.g. allergic bronchopulmonary aspergillosis caused by A. fumigatus. While mucocutaneous infections may be seen in immunocompetent individuals, invasive opportunistic infections occur in the immunosuppressed. The ability of some fungal species to cause disease is due to various virulence factors which help with fungal survival and persistence in the host resulting in tissue damage and disease. These factors include an ability to adhere to hosts' tissues, production of enzymes that cause tissue damage and direct interference with host defences. Some fungi, notably dimorphic fungi and C. albicans have the ability to switch from one form to another (1) . Thermotolerance, at least to 37 0 C, is critical for survival in mammalian host and contributes to dissemination (2).
2.
PATHOGENIC FUNGI OF MEDICAL IMPORTANCE Fungi are eukaryotes that propagate by the production of spores. Most fungi can reproduce both sexually and asexually, and are ubiquitous in the environment. There are three major phyla of fungi to which most of the human pathogenic fungi belong. These are the Ascomycota, Basidiomycota, and Zygomycota.
Ascomycota
The fungi that belong to this group are known as sac fungi (ascus), and are so named because they reproduce sexually by means of ascospores. Sexual reproduction involves the formation of new cells from the fusion of hyphae, this new cell divides to form the ascospores within the ascus. They also reproduce asexually by budding of their conidia which are asexual spores. Asexual reproduction occurs in favourable conditions. Examples of pathogenic fungi in this phyla are dermatophytes, (Microsporum, Trichophyton, and Epidermophyton) dimorphic fungi (Histoplasma capsulatum, Blastomyces dermatitidis, Candida spp, Paracocidioides brasiliensis,and Coccidioides immitis) and septate filamentous fungi (Aspergillus spp).
Zygomycota
Zygomycetes reproduce sexually by the production of zygospores, and asexually by sporangiospores. They form broad aseptate hyphae with fast growing colonies. The fungi in this group are usually contaminants, but they are known to also cause invasive diseases. Examples include Mucorspp, Rhizopusoryzae, and Rhizomucor spp. Basidiomycota The fungi in this group are known as club fungi because they produce sexual spores with a club shaped structure. The sexual spores are known as basidiospores. They reproduce sexually and asexually. They are found in aquatic and terrestrial habitats, and also form ballistospores which are discharged forcefully into the air. Examples of pathogenic forms are Cryptococcus spp, Malasseziaspp, and Trichosporon. 
VIRULENCE FACTORS OF PATHOGENIC FUNGI

Adhesins
Pathogenic fungi are able to cause disease by a number of virulence factors. These factors include structures that enable them to adhere to tissues so as to avoid being cleared or swept away by ciliary movement or mucous. C. albicansas an example is known to have a number of adhesion molecules. C.albicans is able to bind to medical devices forming a biofilm which enhances its pathogenicity (3). The adhesion molecules include Als proteins, Hwp1p, Eap1p, Cshlp and others (4). There are eight genes that code for Als proteins, these proteins mediate adhesion to collagen, laminin, endothelial cells, epithelial cells and cell-to-cell aggregation (5). Hwp1p mediates binding to epithelium while Int1p mediates adhesion to platelets (6). Abrogation of Als3 is the basis for the development of a vaccine to prevent invasive candidiasis (7). Other examples of pathogenic fungi with adhesion molecules include A. fumigatus, H. capsulatumand P. brasiliensis. Conidia of A.fumigatus are covered with hydrophobic proteins known as rodlets. These rodlet proteins are encoded for by RODA and RODB genes and, mediate adhesion of the conidia to albumin and collagen. Receptors on the surface of hyphae include galactomannan and chitin of A. fumigatuswhich mediate adhesion to complement, fibrinogen, immunoglobulin, and surfactant A and D (8). Blastomyces adheres via BAD 1 which binds CR3 and CD14 on phagocytes and also modulates host immune responses (9). H. capsulatumuses HSP60 (10), while P. brasiliensisuses glyceraldehydes 3-phosphate dehydrogenase (GAPDH) and polypeptides p19, p30, p32 (11), and Coccidioides uses its spherule outer wall (SOW) for adhesion (12).
Dimorphism and Thermotolerance
Another way pathogenic fungi become virulent is by morphogenesis. Most pathogenic fungi exhibit dimorphism, that is, they can switch from one form which is not pathogenic to a pathogenic form. While they exist as one morphotype in the environment or as commensals, they exist as another morphotype when they cause infection. Dimorphic fungi include B. dermatitidis, C. immitis, H. capsulatum, P brasiliensis, and C. albicans. They exist as yeast or moulds; yeasts are round or ovoid unicellular organisms. It reproduces by binary fission to yield a separate, independent daughter cell. Moulds on the other hand are filamentous, they grow by apical extension forming cellular units which are separated by septates but still attached to the mould. These branching cellular units are known as hyphae or mycelium. Some fungi may have other morphotypes, for example, C. immitismay form large endosporulatingspherules. Intermediate forms such as pseudohyphae may exist as is seen in C. albicans Ability to grow at elevated temperature is another virulence factor. Fungi that cause systemic infections are able to grow at body temperature and even at febrile temperatures of 38-42 0 C. A. fumigatusisis particularly thermophilic, and can grow at temperatures of up to 55-77 0 C (13). HSP 70 is thought to be required by fungi to adapt to high temperatures (14) . Pathogenic fungi also change from one form to the other at different temperatures, while most fungi exist as mould at ambient temperature; they become yeast at the mammalian temperature which is the pathogenic form. When the transition from mycelia to yeast is blocked in H. capsulatum, the organism continued to grow at 37 0 C but was avirulent (15) . For C. albicans, both forms are pathogenic and, it changes its form in response to changes in the environment existing as the unicellular yeast at lower temperature and acidic pH, which is spread in the environment. The hyphal form is used for tissue invasion (4).
Capsules
Capsulated fungi are usually pathogenic. C. neoformanscoats itself with capsule (glucoronoxymannan) with which it resists phagocytosis. The Polysaccharide capsules are usually prominent in isolates causing infections while environmental C. neoformansisare weakly encapsulated. Acapsular strains are not virulent as they are easily phagocytosed. The genes responsible for encapsulation are CAP 59 and CAP 64 (16) . Capsules also deplete complement and cause a dysregulation of the cytokine network. The capsule also inhibits the mobilisation of leucocytes to the site of infection (17) Production of enzymes Pathogenic fungi release degradative enzymes which enable them to establish disease and disseminate, these enzymes cause tissue damage in the host and impair host immune defences. C. albicanssecretes extracellular phospholipases, lipases and proteases. Pathogenic candida secrete much more phospholipase than commensal strains, and phospholipases A, B, C and D act by breaking the ester bonds. These enzymes are also important for nutrition and Fe acquisition (6,18). C. albicansalso secretes SAP (secreted aspartyl proteinases) which hydrolyse extracellular matrix proteins, coagulation factors such as Hageman factor and factor X, host defence proteins e.g. mucin, IgA andlactoferrin and complements (19). A. fumigatussecretes proteases (serine and aspartic protease, metalloprotease) and phospholipases which degrade elastin present in lung tissue. The serine proteases degrade collagen, fibrin and fibrinogen (2). C. neoformansalso secretes proteases and phospholipases, lysophospholipase and lysophospholipase-transacylase (LPTA). These enzymes destroy lung surfactant and enhance adhesion (20, 21) . In addition, C. neoformansis thought to invade the CNS by the production of urease (22). Urease production is also utilised by Coccidioides, increasing alkalinity at sites of infection and urease deficient strains cannot disseminate (23) .
Defence against reactive oxygen and nitrogen species
Neutrophils and macrophages use oxidative mechanisms (ROS and RNS) to damage fungi by lipid peroxidation and nucleic acid breaks. Pathogenic fungi produce enzymes with which they can be protected from the effects of oxidation. They produce catalases for protection against ROS (24) . C. albicans uses superoxide dismutase and HSP to protect against ROS (25), whileC. Neoformans uses the production of copper, zinc and peroxidase to resist oxidation (26) . A. fumigatusproduces three catalases; Cat-A associated with conidia, and Cat 1p and Cat 2p associated with hyphae (8) as well as superoxide dismutases (containing Mn, Cu and Zn) that protects it from oxidative damage (27) .
Melanin
Melanin is produced by a number of pathogenic fungi, it is hydrophobic and protects against harsh conditions such as UV radiation and increased temperature. It also protects against ROS (27) . In C. neoformans, melanin has been shown to evade anti-fungal damage and inhibit antibody mediated phagocytosis (28) . Melanin is also synthesised by A. fumigatusfrom acetate using a 6 genes pathway (8). H. capsulatum, Blastomyces, P.brasiliensis are other pathogenic fungi which produce melanin (23). 
Iron acquisition
Fe is needed by the fungi for growth, respiration and other metabolic processes, but is not available in the free form in the host. The ability therefore, to obtain Fe from the storage or transport forms in the host is a virulence factor. A. fumigatus uses three mechanisms of Fe uptake; reductase Fe uptake, siderophore-mediated Fe uptake and ferrous Fe uptake mechanisms (29) .
Triacetylfusannine C (TAFC) and desferriferricrocin (DFFC) are two major siderophores identified for A. nidulans (30) . C.albicans acquires iron by different mechanisms which include the use of siderophores, and by direct uptake from heme in red blood cells using haemoglobin receptors (RBT5 family) on their cell surface (31) . C. albicans also employs a reductive mechanism using the reductases -Cfl1/Fre and Cfl95/Fre 10/Rbt 2 (32).
Toxins
A. fumigatus secretes a number of toxins such as aflatoxin and gliotoxin. Aflatoxin does not have any bearing on virulence of A. fumigatus, it is hepatotoxic and carcinogenic. Gliotoxin is immunosuppressive and inhibits phagocytosis by macrophages and T-cell activation (2). It also slows ciliary movement thus making it difficult for the fungal cells to be swept away, and causes damage to the epithelium (33) . Most other fungi produce a number of secondary metabolites that have numerous cellular actions, some of which are probably important in pathogenesis.
The role of Calcineurin and Mannitol
Calcineurin acts as a sensor for pathogenic fungi. It is said to influence the expression of several virulence factors. Calcineurin CNAA gene is important for the growth of A. fumigatus, and contributes to tissue invasion (34). Mannitol is especially used by C. neoformans in CNS infections where it protects the fungi by preventing oxidative damage. It is produced in large quantities and may contribute to brain oedema (35) .
CONCLUSION
Fungal diseases as described are important causes of morbidity and mortality worldwide, affecting mostly the immunosuppressed and the immunocompetent as well. The incidences and associated mortalities of invasive fungal diseases have increased as a result of advancement in treatments, and cancers. The ability of some fungal species to cause disease is due to various virulence factors which help with fungal survival and persistence in the host resulting in tissue damage and disease. A knowledge of these virulence factors is important as research continues towards the development of drugs and vaccines effective in the prevention and treatment of fungal diseases.
